Favorable SCC growth conditions are mediated by the presence of tumor- or stromal-derived growth factors as well as activating mutations in signaling pathways such as PIK3CA or inactivation of the signaling inhibitor PTEN [1, 5, 6]. This evidence concerns the gene PIK3CA and neoplasm.